OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY.


Journal

Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919

Informations de publication

Date de publication:
01 05 2022
Historique:
pubmed: 15 1 2022
medline: 29 4 2022
entrez: 14 1 2022
Statut: ppublish

Résumé

To analyze the retino-choroidal vascular characteristics of patients affected by pigmented paravenous chorio-retinal atrophy by means of optical coherence tomography (OCT) angiography. This study was designed as an observational, cross-sectional case series. Multimodal imaging included fundus autofluorescence, structural OCT, and OCT angiography. The quantitative OCT angiography analyses included the calculation of the vessel density and choriocapillaris porosity. Overall, 12 patients (24 eyes) affected by pigmented paravenous chorio-retinal atrophy were recruited. Structural OCT of the areas involved by pigmented paravenous chorio-retinal atrophy as visualized on the fundus autofluorescence showed a complete ellipsoid zone and external limiting membrane absence, with thinning of ganglion cell complex, outer nuclear layer, and outer plexiform layer, but associated with the optical partial preservation of the retinal pigment epithelium. Optical coherence tomography angiography quantitative assessment of the retinal regions affected by PPRCA, as visualized by fundus autofluorescence, was characterized by normal vessel density at the level of superficial capillary plexus but significantly altered vessel density of deep capillary plexus and choriocapillaris, with higher choriocapillaris porosity. The presence of macular atrophy was significantly correlated with worse deep capillary plexus and choriocapillaris vessel density values. Furthermore, a statistically significant correlation between the fundus autofluorescence patterns and the retinal vascular status was found. Optical coherence tomography angiography quantitative analyses in pigmented paravenous chorio-retinal atrophy demonstrate a specific impairment at the level of the deep capillary plexus, which could in turn bring about a thinning of ganglion cell complex and outer nuclear layer. The alterations at the level of the choriocapillaris and the choroid, in general, could then represent a secondary effect.

Identifiants

pubmed: 35030147
doi: 10.1097/IAE.0000000000003407
pii: 00006982-202205000-00011
doi:

Substances chimiques

Retinal Pigments 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

915-922

Commentaires et corrections

Type : ErratumIn

Références

Noble KG, Carr RE. Pigmented paravenous chorioretinal atrophy. Am J Ophthalmol 1983;96:338–344.
Johansen J, Lund-Andersen C, Autzen T. Pigmented paravenous chorioretinal atrophy. Acta Ophthalmol (Copenh) 1988;66:474–477.
Pearlman JT, Heckenlively JR, Bastek JV. Progressive nature of pigmented paravenous retinochoroidal atrophy. Am J Ophthalmol 1978;85:215–217.
Tsang SH, Sharma T. Pigmented paravenous chorioretinal atrophy (PPCRA). Adv Exp Med Biol 2018;1085:111–113.
Shona OA, Islam F, Robson AG, et al. Pigmented paravenous chorioretinal atrophy: detailed clinical study of a large cohort. Retina 2019;39:514–529.
Lee EK, Lee SY, Oh BL, et al. Pigmented paravenous chorioretinal atrophy: clinical spectrum and multimodal imaging characteristics. Am J Ophthalmol 2021;224:120–132.
Huang HB, Zhang YX. Pigmented paravenous chorioretinal atrophy. Exp Ther Med 2014;7:1439–1445.
Lessel MR, Thaler A, Heilig P. ERG and EOG in progressive paravenous retinochoroidal atrophy. Doc Ophthalmol 1986;62:25–29.
Batioglu F, Atmaca LS, Atilla H, Arslanpence A. Inflammatory pigmented paravenous chorioretinal atrophy. Eye 2002;16:81–84.
Yamaguchi K, Hara S, Tanifuji Y, Tamai M. Inflammatory pigmented paravenous retinochoroidal atrophy. Br J Ophthalmol 1989;73:463–467.
Foxman SG, Heckenlively JR, Sinclair SH. Rubeola retinopathy and pigmented paravenous retinochoroidal atrophy. Am J Ophthalmol 1985;99:605–606.
Peduzzi M, Guerrieri F, Torlai F, Prampolini ML. Bilateral pigmented paravenous retino-choroidal degeneration following measles. Int Ophthalmol 1984;7:11–14.
Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev 2014;13:215–224.
Traversi C, Tosi GM, Caporossi A. Unilateral retinitis pigmentosa in a woman and pigmented paravenous chorioretinal atrophy in her daughter and son. Eye (Lond) 2000;14(Pt 3A):395–397.
McKay GJ, Clarke S, Davis JA, et al. Pigmented paravenous chorioretinal atrophy is associated with a mutation within the crumbs homolog 1 (CRB1) gene. Invest Ophthalmol Vis Sci 2005;46:322–328.
Obata R, Yanagi Y, Iryiana A, Tamaki Y. A familial case of pigmented paravenous retino-choroidal atrophy with asymmetrical fundus manifestation. Graefe’s Arch Clin Exp Ophthalmol 2006;244:874–877.
Shah SM, Schimmenti LA, Chiang J, Iezzi R. Association of pigmented paravenous retinochoroidal atrophy (PPRCA) with a pathogenic variant in the HK1 gene. Retin Cases Brief Rep 2020. Epub ahead of print.
Cicinelli MV, Giuffre C, Rabiolo A, et al. Optical coherence tomography angiography of pigmented paravenous atrophy. Ophth Surg Las Imaging 2018;49:381–383.
Shen Y, Xu X, Cao H. Pigmented paravenous chorioretinal atrophy: a case report. BMC Ophthalmol 2018;18:136.
Parodi MB, Arrigo A, Calamuneri A. Multimodal imaging in subclinical best vitelliform macular dystrophy. Br J Ophthalmol . 2020; bjophthalmol-2020-317635.
Barteselli G. Fundus autofluorescence and optical coherence tomography findings in pigmented paravenous retinochoroidal atrophy. Can J Ophthalmol 2014;49:e144–6.
Niaudet C, Petkova M, Jung B, et al. Adgrf5 contributes to patterning of the endothelial deep layer in retina. Angiogenesis 2019;22:491–505.
Selvam S, Kumar T, Fruttiger M. Retinal vasculature development in health and disease. Prog Retin Eye Res 2018;63:1–19.
Stefater JA, Lewkowich I, Rao S, et al. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011;474:511–515.
Wang Y, Rattner A, Zhou Y, et al. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 2012;151:1332–1344.
Ye X, Wang Y, Cahill H, et al. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 2009;139:285–298.

Auteurs

Maurizio Battaglia Parodi (M)

Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessandro Arrigo (A)

Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Itay Chowers (I)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Martina Jarc-Vidmar (M)

Department of Ophthalmology, University Eye Hospital in Ljubljana, Slovenia.

Michal Shpigel (M)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Francesco Bandello (F)

Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Michel Michaelidis (M)

Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom ; and.
UCL Institute of Ophthalmology, University College London, London, United Kingdom .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH